Sean McCarthy, CytomX Therapeutics CEO
Moderna pivots from a buyout to a platform tech alliance as its struggling partner scores another marquee ally
A day after plucking up a toolmaker for its manufacturing ops in an $85 million buyout, Moderna’s team turned right back around with a tech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
